FluoGuide and ZEISS sign collaboration agreement

The two companies are entering into a strategic collaboration with the goal of developing next-generation solutions in preclinical drug development.

The collaboration includes process development and manufacturing of TIR-01, the active substance in TIRmed’s treatment for atopic dermatitis (eczema), and marks an important step towards future clinical trials.

The manufacturing site, spanning 10,000 m2 is expected to initiate production of Mölnlycke wound care products at the end of 2026/early 2027.

The two companies have announced a strategic collaboration to advance next-generation biotherapeutics, they state.

Neogap Therapeutics has been awarded a SEK 1 million grant from Vinnova to initiate a collaborative project with Weill Cornell Medicine in New York, US.

Karolinska ATMP Center and ATMP Center Uppsala have signed a letter of intent to deepen cooperation in the rapidly growing medical field of advanced therapies (ATMP), which includes medicines based on cells and genes.

FluoGuide is in advanced negotiations with a world leading medical technology company on a collaboration agreement within head and neck cancer surgery where the aim is to optimize the usage of imaging systems and FG001 to enable better treatment for patients with cancer.